A previous study demonstrated that, in contrast to bulk tumor cells, rare CD133+CD44+ CCSCs are notably distinct at the genomic, morphological and functional levels, showing extensive self-renewal ability in vivo and in vitro and possessing the capacity to produce different cell phenotypes [23, 47]. The gene discussed is CD44; the disease is neoplasm.